Reaction Details Report a problem with these data
Target
Platelet-activating factor receptor
Ligand
BDBM50018386
Substrate
n/a
Meas. Tech.
ChEBML_154996
IC50
60±n/a nM
Citation
 Guthrie, RW; Kaplan, GL; Mennona, FA; Tilley, JW; Kierstead, RW; Mullin, JG; LeMahieu, RA; Zawoiski, S; O'Donnell, M; Crowley, H Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor. J Med Chem 32:1820-35 (1989) [PubMed]  Article 
Target
Name:
Platelet-activating factor receptor
Synonyms:
PAF Platelet activating factor | PAF-R | PAFR | PTAFR | PTAFR_HUMAN | Platelet activating factor receptor | Platelet-activating factor receptor
Type:
Enzyme Catalytic Domain
Mol. Mass.:
39219.60
Organism:
Homo sapiens (Human)
Description:
PAF Platelet activating factor PTAFR HUMAN::P25105
Residue:
342
Sequence:
MEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKKFNEIKIFMVNLTMADMLFLITLPLWIVYYQNQGNWILPKFLCNVAGCLFFINTYCSVAFLGVITYNRFQAVTRPIKTAQANTRKRGISLSLVIWVAIVGAASYFLILDSTNTVPDSAGSGNVTRCFEHYEKGSVPVLIIHIFIVFSFFLVFLIILFCNLVIIRTLLMQPVQQQRNAEVKRRALWMVCTVLAVFIICFVPHHVVQLPWTLAELGFQDSKFHQAINDAHQVTLCLLSTNCVLDPVIYCFLTKKFRKHLTEKFYSMRSSRKCSRATTDTVTEVVVPFNQIPGNSLKN
  
Inhibitor
Name:
BDBM50018386
Synonyms:
5,5-Bis-(4-methoxy-phenyl)-penta-2,4-dienoic acid (1-cyclopropyl-4-pyridin-3-yl-butyl)-amide | CHEMBL53029
Type:
Small organic molecule
Emp. Form.:
C31H34N2O3
Mol. Mass.:
482.6133
SMILES:
[#6]-[#8]-c1ccc(cc1)-[#6](=[#6]\[#6]=[#6]\[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-c1cccnc1)-[#6]-1-[#6]-[#6]-1)\c1ccc(-[#8]-[#6])cc1
Structure:
Search PDB for entries with ligand similarity: